|
Volumn 31, Issue 1, 2004, Pages 163-166
|
Etidronate Prevents High Dose Glucocorticoid Induced Bone Loss in Premenopausal Individuals with Systemic Autoimmune Diseases
|
Author keywords
Autoimmune disease; Etidronate; Glucocorticoid osteoporosis
|
Indexed keywords
ALFACALCIDOL;
ETIDRONIC ACID;
GLUCOCORTICOID;
METHYLPREDNISOLONE;
PREDNISOLONE;
ADOLESCENT;
ADULT;
ARTICLE;
AUTOIMMUNE DISEASE;
BONE DENSITY;
BONE MINERAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID INDUCED OSTEOPOROSIS;
CORTICOSTEROID THERAPY;
DISEASE MARKER;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
FEMUR NECK;
HUMAN;
LUMBAR SPINE;
MALE;
OSTEOLYSIS;
PREMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
SYSTEMIC DISEASE;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
AUTOIMMUNE DISEASES;
BONE DENSITY;
BONE RESORPTION;
DRUG THERAPY, COMBINATION;
ETIDRONIC ACID;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
HYDROXYCHOLECALCIFEROLS;
MALE;
PREMENOPAUSE;
|
EID: 0346057891
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (33)
|
References (7)
|